Refractory Transformed Non-Hodgkin Lymphoma

specific

A transformed non-Hodgkin lymphoma that is resistant to treatment.

22

Centers

19

Active Trials

Cancer Funding

Top Centers for Refractory Transformed Non-Hodgkin Lymphoma(22)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.7
2
High-Volume Research Center
72.7
3
NCI Comprehensive
Active Research Program
55.3
4
NCI Comprehensive
Active Research Program
55.3
5
NCI Comprehensive
Active Research Program
55.3
6
NCI Comprehensive
Active Research Program
55.3
7
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
55.3
8
NCI Comprehensive
Active Research Program
55.3
9
NCI Comprehensive
Active Research Program
55.3
10
NCI Comprehensive
Active Research Program
55.3
11
NCI Comprehensive
Active Research Program
55.3
12
NCI Comprehensive
Active Research Program
55.3
13
NCI Comprehensive
Active Research Program
55.3
14
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
55.3
15
Active Research Program
55.3
16
Active Research Program
55.3
17
Active Research Program
55.3
18
NCI Comprehensive
34.9
1934.9
20
NCI Comprehensive
34.9
2134.9
2234.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →